|
INTRODUCTION
Increases in disease
awareness, better compliance with preventive medicine
and exposure to high technology acute care management
have helped to improve life expectancy and have subsequently
led to an aging society (1). The elderly constitute
more than 12.5 % of the USA population; but account
for 33% of all hospital admissions. Most visits to
physicians and most personal and insurance resources
are spent on healthcare for this age group.(1,
2, 3).
Polypharmacy among the elderly
population, though considered within the norms in
terms of the number of medications taken due to the
wide prevalence of disease among this age group, leads
to higher adverse drug reactions in these relatively
fragile patients or those with impaired pharmacokinetics
and pharmaco-dynamics(4).
Higher incidences of inappropriately
prescribed medications in the elderly are due to several
factors, and lead to higher incidence of hospital
admissions, deaths and subsequently higher costs(5,6).
Saudi Aramco Medical Services Organization (JCIA Accredited)
provides out-patient and in-patient care for more
than 184,000 patients, 3.4% of them above 60 years.
Patients are exposed to high technology acute medical
care and preventive medical services teams of all
disciplines supported by a user-friendly computer-based
system for in and out patient services that incorporate
detailed patient information, drug information, contra-indications
specifications and a high alert list. In 1993, the
elderly population above 65 years of age in Saudi
Arabia constituted only 2.6% (WHO World Health Report,
2001). Currently, it is postulated that the number
has greatly increased due to important and continued
governmental and private sector interest in health
care over the past two decades. A recent report from
Saudi Arabia showed the ratio "of one hospital
bed per 476 people and one doctor per 690 people [to
be] among the lowest in the world" (Saudi Arabia
publication spring 2002 Magazine: Health).
OBJECTIVES
A brief review of literature
on the extent and risk factors of polypharmacy in
elderly population is intended to increase physicians'
and patients' awareness of polypharmacy, as well as
list methods used by experts in the field to avoid
inappropriate prescribing of medications in an out-patient
setting.
DISCUSSION
Elderly patients above 65
years use more than 30% of prescription medications
and 50% of over-the-counter medications(2).
The aging process naturally leads to impaired functional
capacity of organs such as lungs, liver, kidneys as
well as relative reduction of the immune system. Prevalence
of cardiopulmonary diseases, strokes, diabetes, osteoporosis,
osteoarthritis, falls and malignancy among elderly
population entail multiple clinic visits to primary
care physicians and to different other specialists
and sub-specialists. This leads to the elderly using
more medications than younger age groups. More prescribed
medications, over-the-counter medications, and herbal
products lead naturally to more drug side-effects
(1, 4). Garcia recently reported that more
than 30% of the elderly population are admitted because
of adverse drug effects and more than 50% of these
adverse effects can be prevented through appropriate
prescribing (5). Fick et. al. in 2000 reported 106,000
medication-related deaths at a cost of $85,000,000
to US Healthcare(6). Fifty one percent
of all deaths occurred in elderly patients over 60
years of age and 35% of ambulatory elderly experience
and adverse drug event over a one-year period(5).
Decreased functional capacity of vital organs at old
age coupled with higher rate of prescribed drugs leads
to more serious drug side effects even at lower doses
of medications. Commonly used drugs (beta blockers,
calcium channel blockers, ACE inhibitors, H1, H2 blockers,
Aspirin, NSAIDs, calcium, biphosphonates, antidepressants
and anti-epileptics) can lead to more serious drug
results if not appropriately prescribed. Beers' criteria,
developed in 1991, updated in 1997 and then in 2003,
list a number of medications that are recognized as
inappropriate in elderly based on consensus guidelines
and experts' opinion(6, 7). Fluoxetine,
non-COX-selective NSAIDs, Benzodiazepines are listed
due to risk of excessive CNS stimulation, GI bleeding
and sedation respectively. Garcia's(5)
literature review of evidence-supported studies aimed
at reducing inappropriate prescribing in the elderly
suggested the following four methods:
- Using pharmacist recommendations
can help in reducing polypharmacy through his/her
proper screening of patient's drug profile, reviewing
potential drug - drug interactions, assessing effect
of co-morbid conditions, with recommendations or
suggestions to physicians who are part of the multidisciplinary
team(5,8).
- Computerized alerts in
an in-patient setting decreased serious medication
errors and adverse drug events. Medical practitioners
and pharmacists in our health center, have access
to a computerized data system that includes all
pertinent patient information in both the in-patient
and out-patient setting; this has helped to make
an adequate decision. A multidisciplinary team consisting
of a clinical pharmacist, a physician and a health
educator is well established and all aim toward
prescribing the proper medications and removing
others of no apparent indication or with high side
effects.
- Another proven method
of reducing inappropriate prescribing in the elderly
can be achieved through regular patient education
sessions. Patients are encouraged to keep a list
of medications taken, including over the counter
and herbal medications.
- Physicians' regular review
of medications taken by their elderly patients,
though time consuming, with the help of the pharmacist
consultant and health educators, can reduce significantly
serious adverse drug events(5,8,9).
The Institute of Medicine
(IOM) reported 1.5x10(6) preventable drug
adverse reaction each year in USA. Jenkins and Vaida(9)
recommended the following office-based strategies
whether physicians are using paper or electronic charts
to avoid medication errors:
- Proper patient identification
- Document allergies and
drug reactions
- Highlight significant medical
conditions
- Keep current update of
all medications (prescriptions, OTC, herbal with
each clinic visit)
- Keep current medication
information most commonly used
- When writing prescriptions,
improve hand writing, avoid abbreviations in names,
dosages and frequency of each drug prescribed
- Make sure patients and/or
caretakers understand specific recommendation of
each drug prescribed
- Consider using electronic
system of prescribing; "Electronic prescribing
system can produce computer generated prescriptions
or can electronically transmit the prescription
directly to the Pharmacy." The Institute of
Medicine recommended all prescribers should adopt
an electronic system by year 2010(9)
Buschardt and Jones(10)
highlighted important inquiries to be followed that
might help in assessing and limiting inappropriate
prescribing in the elderly:
- "Is each medication
necessary," including OTC and herbal products?
Use only drugs that are evidence supported.
- "Is the drug contraindicated
in the elderly?" Avoid high risk medications
in the elderly e.g. long acting Benzodiazepines
associated with sedation and falls, NSAIDs with
CNS, GI and renal implications.
- "Are there duplicate
medications?"
- "Is the patient taking
the lowest effective dosage?" Concept of drug
prescribed in elderly to 'start low and go slow'
due to natural functional impairment in renal function,
liver metabolism and co-morbidity at old age.
- "Is the medication
intended to treat side effects of another medication?"
Avoid such practice e.g. Anti-tussives used to treat
ACE induced cough.
- "Can I simplify a
drug regimen?" Try to use the easiest for the
patient.
- "Are there potential
drug interactions?" Try to avoid them.
CONCLUSION
Polypharmacy in the
elderly is a universal problem with serious impacts
on patients' health and community resources. Reviewing
the literature, we provided the evidence that safe
use of medication remains multidisciplinary team-work.
Physicians are more challenged for most effective
use of office visits/inpatient encounters to apply
evidence-based procedures to avoid serious drug events.
Pharmacists, health educators' suggestions, and patients'
compliance remains a standard rule to increase chances
for better prescribing practices.
|
|
REFERENCES
| 1. |
David A. Lipschidz,
Robert J. Reis, Dennis H. Sullivan; The Biology
of Aging. Chapter 132 in Cecil Essentials of Medicine
5th Edition, pages 1003 -1010, 2001. |
| 2. |
Beyth RJ, Shorr RL;
Principles of Drug Therapy in Older Patients:
Rational Drug Prescribing. Clin Geriatr Med. 2002;
18:577-592. |
| 3. |
Denneboom W, Dautzenberg
MG, Grol R, DeSmet PA; Analysis of polypharmacy
in Older Patients in Primary Care using a Multidisciplinary
Expert Panel. Br J Gen Pract. 2006 July; 56 (528):
504-510. |
| 4. |
Futton MM, Allen ER;
Polypharmacy in the Elderly: A Literature Review.
J Am. Acad Nurs Pract. 2005, 17 (4):123-32. |
| 5. |
Garcia RM. Five Ways
You Can Reduce Inappropriate Prescribing in the
Elderly: A Systemic Review. (The Journal of Family
Practice April 2006. Vol, 55, no 4: 305-312 )
J Fam Pract. 2006 Apr; 55 (4): 304-12. |
| 6. |
Fick DM, Coopar JW,
Wade WE, Waller JL, MacLean JR, Beers NH. Updating
the Beers Criteria for Potentially Inappropriate
Medications Use in Older Adults: Results of a
US Consensus panel of experts. Arch Intern Med
2003; 163:2716-2724. |
| 7. |
Beers N H. Explicit
Criteria for Determining Potentially Inappropriate
Medications Use by the Elderly. An Update. Arch
Intern Med. 1997; 157 (14):1531-1536. |
| 8. |
Craig, DS. Reduction
of High Risk Polypharmacy Drug Combination in
Patients in a Managed Care Setting. Pharmacotherapy
June 2006; 26 (6): 886-7. |
| 9. |
Jenkins RH, Viada AJ.
Simple Strategies to Avoid Medication Errors.
Family Practice Management. 2007 February; 14
(2): 14-47. |
| 10. |
Bushardt, RL, Jones
KW. Nine Key Questions to Address Polypharmacy
In The Elderly. JAAPA, 2005 May, 18 (5): 32-7. |
Acknowledgment
The authors wish to
acknowledge the use of Saudi Aramco Medical Services
Organization facilities for the data and the study,
which resulted in this paper. The authors are employed
by Saudi Aramco during which the study was conducted
and the paper written.
|